Zoekresultaten - 7 results
Epidemiologie van infectieziekten die voorkomen kunnen worden door vaccinatie. Samenvattend jaarverslag 2018
Adrien Lajot; Marie Lesenfants; Amber Litzroth Source: Sciensano, Brussels (2019) Accession Number: D/2019/14.440/106 Health Topics: Measles Meningitis Tetanus Infantile paralysis Rubella Mazelen Rougeole ...
Epidémiologie des maladies infectieuses à prévention vaccinale. Synthèse annuelle 2018
E Poliomyelitis (polio) Measles Rubella Tetanus Diphtérie Difterie Hépatites A, B, C, D et E Hepatitis A, B, C, D en E Poliomyélite (polio) Poliomyelitis (polio) Mazelen Rougeole Rubella Rubéole Tetanus Tétanos ...
Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for Tetanus Vaccine (Adsorbed) Batch 3).
Pig Pigs PRODUCTS Quality Regulatory relative Requirements result results routine Sample serology stability STANDARD standards study Test TESTING tests Tetanus use vaccine vaccines variation WHO world ...
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium36577
Antibodies,Bacterial Antibodies,Viral Antibody Antwerp article at Belgium blood Child Child,Preschool Diphtheria Diphtheria-Tetanus Vaccine disease Diseases electronic epidemiology EVALUATION Female Group health Humans ...
Implementation over the past 20 years of the 3R's principle for batch release at the Scientific Institute of Public Health, Belgium (IPH).
Tetanus time toxicity use vaccine vaccines VALIDATION Validation study Weight Weight gain Weight-gain world Abstract: For the batch release of vaccines on the European market, a limited number of quality ...
Collaborative Study for the Validation of Alternative in vitro Potency Assays for Human Tetanus Immunoglobulin
study System Term Test TESTING Tetanus time Validate VALIDATION values work Abstract: The European Pharmacopoeia (Ph. Eur.) monograph Human tetanus immunoglobulin (0398) gives a clear outline of the in ...
Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.
M Immunotherapy Lymphocytes Male middle aged Mycobacterium Mycobacterium bovis Recombinant Proteins Tetanus Toxoid Tuberculin Urinary Bladder Neoplasms Abstract: Few studies have analysed the antibody response ...